Skip to main content
Breast Cancer Research : BCR logoLink to Breast Cancer Research : BCR
. 2025 Jan 7;27:3. doi: 10.1186/s13058-024-01952-0

Correction: c-MET-positive circulating tumor cells and cell-free DNA as independent prognostic factors in hormone receptor-positive/HER2-negative metastatic breast cancer

Jieun Park 1, Eun Sol Chang 2,3, Ji-Yeon Kim 4, Chaithanya Chelakkot 5,6, Minjung Sung 3, Ji-Young Song 3, Kyungsoo Jung 7, Ji Hye Lee 6, Jun Young Choi 8, Na Young Kim 8, Hyegyeong Lee 9, Mi-Ran Kang 10, Mi Jeong Kwon 11,12, Young Kee Shin 1,6,8,, Yeon Hee Park 4,, Yoon-La Choi 2,3,7,
PMCID: PMC11707997  PMID: 39773237

Correction to: Park et al. Breast Cancer Research (2024) 26:13

10.1186/s13058-024-01768-y

Following the publication of the original article, the authors reported that an abbreviation in the Background section of the manuscript, specifically, in the fourth paragraph, was inaccurate.

Incorect

Mesenchymal-epithelial transition factor (MET).

Correct

MET (MNNG-HOS transforming gene).

The Original Article has been corrected.

Footnotes

The online version of the original article can be found at 10.1186/s13058-024-01768-y.

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Contributor Information

Young Kee Shin, Email: ykeeshin@snu.ac.kr.

Yeon Hee Park, Email: yhparkhmo@skku.edu.

Yoon-La Choi, Email: ylachoi@skku.edu.


Articles from Breast Cancer Research : BCR are provided here courtesy of BMC

RESOURCES